YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.

Browsing by Author "Karaman, Y."

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Thumbnail Image
    Book Part
    Epidemiology and Clinical Features of Preeclampsia
    (Nova Science Publishers, Inc., 2020) Karaman, E.; Dirik, D.; Karaaslan, O.; Rapisarda, A.M.C.; Fichera, M.; Karaman, Y.
    Preeclampsia is one of most important hypertensive disorders of pregnancy. It is characterized by the new onset of hypertension and proteinuria, or of hypertension and significant end-organ dysfunction with or without proteinuria, in the last half of gestation or postpartum. It complicates about 2-8% of gestations and it is a well-known cause of maternal-perinatal morbidity and mortality. The risk factors for development of preeclampsia include genetic factors, sperm exposure, maternal smoking, pre-existing medical conditions (such as hypertension, diabetes mellitus, chronic kidney disease and anti-phospholipid syndrome), and miscellaneous ones such as nulliparity, older maternal age and obesity. The clinical presentation of preeclampsia is varied. The main symptoms are headache, visual symptoms (including blindness), epigastric pain or nausea and vomiting. Preeclampsia is classified as mild and severe based on the degree of hypertension, laboratory and clinical findings. The most severe form is the development of eclampsia and HELLP syndrome. © 2020 by Nova Science Publishers, Inc. All rights reserved.
  • Thumbnail Image
    Article
    Evaluation of Hemoglobin A1c Levels in Endometrial Cancer Patients: a Retrospective Study in Turkey
    (Asian Pacific Organization for Cancer Prevention, 2015) Karaman, E.; Karaman, Y.; Numanoglu, C.; Ark, H.C.
    Background: Hemoglobin A1c(HgA1c) is a marker of poor gylcemic control and elevation HgA1c is associated with increased risk of many cancers. We aimed to determine the HgA1c levels in endometrial cancer cases and any relationship with stage and grade of disease. Materials and Methods: A retrospective data review was performed between June 2011 and October 2012 at a tertiary referral center in Turkey. The study included 35 surgically staged endometrial cancer patients and 40 healthy controls. Preoperative HgA1c levels drawn within 3 months before surgery were compared. Also the relationships between HgA1c levels and stage, grade and hystologic type of cancer cases were evaluated. Results: The mean HgA1c levels were statistically significantly higher at 6.19±1.44 in endometrial cancer cases than the 5.61±0.58 in controls (p=0.027). With endometrial cancer cases, the mean HgA1c level was found to be 6.62±1.40 for stage I and 6.88±1.15 for stages II-IV (p=0.07). The figures were 6.74±1.65 for endometrioid and 6.63±1.41 for non-endometrioid type tumors (p=0.56). Mean HgA1c levels of 6.72±1.14 for grade 1 and 6.62±1.42 for grade 2-3 were observed (p=0.57). Conclusions: HgA1c levels in endometrial cancer patients were statistically higher than healthy controls. However, HgA1c did not show any significant correlation with stage, grade and histologic type in endometrial cancer cases.